A recently-published Phase 3 study conducted by the London School of Hygiene and Tropical Medicine (LSHTM) and partners in Burkina Faso and Mali found that not only was the impact of seasonal vaccination with RTS,S/AS01_E (RTS,S) comparable to that of seasonal malaria chemoprevention (SMC), but that combining the two interventions reduced malaria episodes and deaths in children by about 70 percent compared to either intervention alone.